THERACLION

Specialising in
the non-invasive
treatment of tumours

READ MORE

ECHOTHERAPY

An innovative solution using focused, guided ultrasound

READ MORE

ECHOPULSE®

A disruptive innovation

READ MORE

Investors area

Click here for financial information

READ MORE

About us


Theraclion is a French company specialising in high-tech therapeutic ultrasound equipment. We design and market Echopulse®, an innovative echotherapy solution.

READ MORE

Our product: Echopulse®


The Echopulse® device combines focused ultrasound therapy with ultrasound imaging for accurate, tailored and non-invasive treatment of tumours.

READ MORE

Pathologies treated


Echopulse®, Theraclion's echotherapy solution, has obtained CE marking for two pathologies: breast fibroadenomas and thyroid nodules.


READ MORE



Echotherapy: an innovative solution


Echotherapy is a unique combination of high-intensity focused ultrasound (HIFU) therapy and real-time ultrasound monitoring.
It's a viable alternative to surgery and to monitoring, enabling the non-invasive treatment of benign tumours (breast fibroadenomas and thyroid nodules) without scarring.


EN SAVOIR PLUS



Testimonial


Dr Marc Abehsera

Radiologist at the American Hospital of Paris - France

« In the HIFU treatment of breast fibroadenoma, first results are encouraging for an outpatient technique very well tolerated with significant fibroadenoma’s volume reductions.»

Plenary session presentation - JFR 2012

READ THE OTHER TESTIMONIALS

Stay informed about the opening of future Echotherapy centers nearest to you, by clicking here

I would like to be informed of the opening of future Echotherapy centers



Interested in:







*:required fields










Echopulse® is a medical device designed and marketed by Theraclion for use by health professionals in treating patients with breast fibroadenomas and benign thyroid nodules. It is a regulated health product and, in accordance with the above Act, it bears the CE marking. Consult your health professional before any procedure.